Bhumika Rath
About Bhumika Rath
Data last updated:
Bhumika Rath has 4 years in corporate governance. Holds Director and Additional Director roles. Currently with 6 companies, including Angikya Software & Technologies Limited and Bhoomika Healthcare Limited. Engaged in Technology, Healthcare and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Angikya Software & Technologies Limited U72502OR2022PLC040203 | Director | 06 Jul 2022 | 2022 | Active |
| Bhoomika Healthcare Limited U85110OR2020PLC034530 | Additional Director | 08 Feb 2022 | 2020 | Active |
| Brosch Pharma Private Limited U21001OD2024PTC046383 | Director | 16 Jul 2024 | 2024 | Active |
| Devombhoomika Healthcare Private Limited U86100OD2025PTC051922 | Director | 27 Dec 2025 | 2025 | Active |
| Tinnotu Solution Private Limited U73100OD2024PTC046196 | Director | 26 Jun 2024 | 2024 | Active |
| Owlbowl Private Limited U47912OD2023PTC042976 | Director | 22 Jun 2023 | 2023 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhumika Rath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhumika Rath
Bhumika Rath has 4 years in corporate governance. Holds Director and Additional Director roles. Currently with 6 companies, including Angikya Software & Technologies Limited and Bhoomika Healthcare Limited. Engaged in Technology, Healthcare and more. Contributes to corporate operations.
Bhumika Rath is associated with 6 companies as Director and Additional Director.
Bhumika Rath has expertise in Technology, Healthcare and other sectors.
Bhumika Rath has 4 years in corporate governance.